{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:19:08Z","timestamp":1791148748533,"version":"4.1.0"},"reference-count":52,"publisher":"BMJ","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pathol"],"published-print":{"date-parts":[[1983,11]]},"abstract":"<jats:p>Bone marrow transplantation is now an accepted component in the overall therapy of acute and chronic (myeloid) leukaemia for some selected patients. Some of the obstacles to success have been partially overcome. Many advances in supportive care have been made. Pneumocystis carinii and herpes simplex infections are preventable. Effective decontamination of the gastrointestinal tract for bacteria and fungi is now readily achievable and may have reduced the risk of serious systemic infections. New antibiotics which, in combination, are effective in life-threatening infections are under study. Recent developments in the prevention or amelioration of graft versus host disease (GvHD) have included T lymphocyte depletion in the donor marrow and the use of the fungal polypeptide cyclosporin A. Less than 10% of patients would now be expected to succumb to this complication. Outstanding problems remaining to be resolved are the improvement in the antileukaemic conditioning prior to transplantation and the prevention or treatment of cytomegalovirus infection in the seropositive recipient. This infection can cause pneumonitis and is currently the single most frequent transplant related cause of mortality.<\/jats:p>","DOI":"10.1136\/jcp.36.11.1207","type":"journal-article","created":{"date-parts":[[2007,6,9]],"date-time":"2007-06-09T00:50:46Z","timestamp":1181350246000},"page":"1207-1214","source":"Crossref","is-referenced-by-count":20,"title":["A review of the current status and techniques of allogeneic bone marrow transplantation for treatment of leukaemia."],"prefix":"10.1136","volume":"36","author":[{"given":"H G","family":"Prentice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1983,11,1]]},"reference":[{"key":"ref_1","first-page":"197","article-title":"Modification of irradiation injury in mice and guinea pigs by bone marrow injections","volume":"12","author":"Lorenz, E.; Uphoff, D.; Reid, T.R.; Shelton, E.","year":"1951","unstructured":"Lorenz E, Uphoff D, Reid TR, Shelton E. Modification of irradiation injury in mice and guinea pigs by bone marrow injections. J Natl Cancer Inst 1951;12: 197-201.","journal-title":"J Natl Cancer Inst"},{"key":"ref_2","first-page":"746","article-title":"The role of the spleen in radiation injury and recovery","volume":"35","author":"Jacobson, L.O.; Simmons, E.L.; Marks, E.K.; Robson, M.J.; Bethard, W.F.; Gaston, E.O.","year":"1950","unstructured":"Jacobson LO, Simmons EL, Marks EK, Robson MJ, Bethard WF, Gaston EO. The role of the spleen in radiation injury and recovery. J Lab Clin Med 1950;35:746-70.","journal-title":"J Lab Clin Med"},{"key":"ref_3","first-page":"63","article-title":"Clinical immunobiology","volume":"2","author":"Good, R.A.","year":"1974","unstructured":"Good RA, Bach FJ. In: Bach FH, Good RA, eds. Clinical immunobiology. New York: Academic Press, 1974;2:63-114."},{"key":"ref_4","first-page":"51","article-title":"One hundred patients with acute leukemia treated by chelotherapy, total body irradiation, and allogeneic marrow transplantation","volume":"49","author":"Thomas, E.D.; Buckner, C.D.; Banahi, M.","year":"1977","unstructured":"Thomas ED, Buckner CD, Banahi M, et al. One hundred patients with acute leukemia treated by chelotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 1977;49:51 1-33.","journal-title":"Blood"},{"key":"ref_5","article-title":"Report of the Working Group on Bone Marrow Transplantation. Sir Douglas Black","year":"1982","unstructured":"Report of the Working Group on Bone Marrow Transplantation. Sir Douglas Black London: HMSO, 1982."},{"key":"ref_6","first-page":"87","volume":"26","author":"Bluttransfus, Haematol","year":"1981","unstructured":"Haematol Bluttransfus 1981;26:87-93."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0145-2126(79)90036-5","article-title":"Combination chemotherapy and radiotherapy for acute lymphocytic leukemia in adults: Results of CALGB protocol 7113","volume":"3","author":"Henderson, E.S.; Scharlau, C.; Cooper, M.R.","year":"1979","unstructured":"Henderson ES, Scharlau C, Cooper MR, et al. Combination chemotherapy and radiotherapy for acute lymphocytic leukemia in adults: Results of CALGB protocol 7113. Leuk Res 1979;3:395-407.","journal-title":"Leuk Res"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1182\/blood.V59.2.334.334","article-title":"Moderate dose methotrexate, vincristine, asparaginase and dexamethasone for treatment of adult acute lymphocytic leukaemia","volume":"59","author":"Estehay, R.J.; Wiernik, P.H.; Grove, W.R.; Markus Susan, D.; Wesley Margaret, N.","year":"1982","unstructured":"Estehay RJ, Wiernik PH, Grove WR, Markus Susan D, Wesley Margaret N. Moderate dose methotrexate, vincristine, asparaginase and dexamethasone for treatment of adult acute lymphocytic leukaemia. Blood 1982;59:334-45.","journal-title":"Blood"},{"key":"ref_9","article-title":"The role of intensive postinduction chemotherapy in the management of patients with acute myelogenous leukaemia. Cancer Treat Rep 1982; 66: 1455-61. '\u00b0 Steinmuller D, Pittlekow M. Donor-recipient matching with the mixed lymphocyte-epidermal cell reaction","unstructured":"The role of intensive postinduction chemotherapy in the management of patients with acute myelogenous leukaemia. Cancer Treat Rep 1982;66:1455-61. '\u00b0 Steinmuller D, Pittlekow M. Donor-recipient matching with the mixed lymphocyte-epidermal cell reaction. J Cell Biochem","journal-title":"J Cell Biochem"},{"key":"ref_10","first-page":"69","article-title":"supp 7A: Abs 0183: 73. \" Sondel PH, et al. Graft versus leukaemia","year":"1983","unstructured":";supp 7A:Abs 0183:73. \" Sondel PH, et al. Graft versus leukaemia. J CeUl Biochem 1983;supp 7A:Abs 0172:69.","journal-title":"J CeUl Biochem; supp 7A: Abs 0172"},{"key":"ref_11","article-title":"Personal communication","author":"HLA, Storb R.; GvHD","year":"1982","unstructured":"Storb R. HLA and GvHD. Personal communication. 1982."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0140-6736(83)91793-2","article-title":"Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia","volume":"i:","author":"Powles, R.L.; Kay, H.E.M.; Clink, H.M.","year":"1983","unstructured":"Powles RL, Kay HEM, Clink HM, et al. Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia. Lancet 1983;i:612-5.","journal-title":"Lancet"},{"key":"ref_13","first-page":"159","article-title":"mercaptoethane sulphonate sodium (Mesnum) in patients with advanced carcinoma. Lancet 1980; ii: 657-9. \" Barrett A. Clinical aspects of total body irradiation","volume":"3","year":"1982","unstructured":"-mercaptoethane sulphonate sodium (Mesnum) in patients with advanced carcinoma. Lancet 1980;ii:657-9. \" Barrett A. Clinical aspects of total body irradiation. J Eur Radiother 1982;3:159-64.","journal-title":"J Eur Radiother"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.7326\/0003-4819-86-2-155","article-title":"Bone marrow transplantation with intensive combination chemotherapy\/ radiation therapy (SCARI) in acute leukemia","volume":"86","author":"Group, U.C.L.A.Bone Marrow Transplantation","year":"1977","unstructured":"UCLA Bone Marrow Transplantation Group. Bone marrow transplantation with intensive combination chemotherapy\/ radiation therapy (SCARI) in acute leukemia. Ann Intern Med 1977;86:155-61.","journal-title":"Ann Intern Med"},{"key":"ref_15","first-page":"227","article-title":"Bone marrow transplantation in acute leukemia","volume":"19","author":"Santos, W.; Kaizer, H.","year":"1982","unstructured":"Santos W, Kaizer H. Bone marrow transplantation in acute leukemia. Semin Hematol 1982;19:227-39.","journal-title":"Semin Hematol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0140-6736(82)90003-4","article-title":"ABOincompatible bone-marrow transplantation: removal of red blood cells from donor marrow avoiding recipient antibody depletion","volume":"ii:","author":"Blacklock, H.A.; Prentice, H.G.; Evans, J.P.M.","year":"1982","unstructured":"Blacklock HA, Prentice HG, Evans JPM, et al. ABOincompatible bone-marrow transplantation: removal of red blood cells from donor marrow avoiding recipient antibody depletion. Lancet 1982;ii:1061-4.","journal-title":"Lancet"},{"key":"ref_17","article-title":"T cell depletion using OKT3 and rabbit complement to prevent acute graft versus host disease in allogeneic bone marrow transplantation. Exp Hematol 1983","unstructured":"T cell depletion using OKT3 and rabbit complement to prevent acute graft versus host disease in allogeneic bone marrow transplantation. Exp Hematol 1983 (in press)."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00007890-197003000-00007","article-title":"Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts","volume":"9","author":"Storb, R.; Epstein, R.B.; Graham, T.C.","year":"1970","unstructured":"Storb R, Epstein RB, Graham TC, et al. Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts. Transplantation 1970;9:240-6.","journal-title":"Transplantation"},{"key":"ref_19","first-page":"302","article-title":"Graft-versus-Host disease and survival In patients with aplastic anemia treated by marrow grafts from HLA-identical siblings","volume":"380","author":"Storb, R.; Prentice, R.L.; Buckner, C.D.","year":"1983","unstructured":"Storb R, Prentice RL, Buckner CD, et al. Graft-versus-Host disease and survival In patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. N Engl J Med 1983;380:302-7.","journal-title":"N Engl J Med"},{"key":"ref_20","first-page":"1017","article-title":"Effects of the new anti-lymphocytic peptide cyclosporin A in animals","volume":"32","author":"Borel, J.F.; Feurer, C.; Magnee, C.; Stahelin, H.","year":"1977","unstructured":"Borel JF, Feurer C, Magnee C, Stahelin H. Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology 1977;32:1017-25.","journal-title":"Immunology"},{"key":"ref_21","first-page":"1327","article-title":"Cyclosporin A for the treatment of graft-versus-host disease in man","volume":"ii:","author":"Powles, R.L.; Clink, H.; Sloane, J.; Barrett, A.J.; Kay, H.E.M.; McElwain, T.J.","year":"1978","unstructured":"Powles RL, Clink H, Sloane J, Barrett AJ, Kay HEM, McElwain TJ. Cyclosporin A for the treatment of graft-versus-host disease in man. Lancet 1978;ii:1327-31.","journal-title":"Lancet"},{"issue":"9","key":"ref_22","first-page":"\"2S\" # \"1392","article-title":"Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone marrow transplantation","volume":"327","author":"Powles, R.L.; Cink, H.M.; Spence, D.","year":"1980","unstructured":"Powles RL, Cink HM, Spence D, et al. Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone marrow transplantation. Lancet 1980;i:327-9. 2S Shulman H, Striker G, Deeg HJ, Kennedy M, Storb R, Thomas ED. Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation. N Engl J Med 1981;305:1392-5.","journal-title":"Lancet; Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00007890-196807000-00009","article-title":"The selective elimination of immunologically competent cells from bone marrow and lymphatic cell mixtures","volume":"6","author":"Dicke, K.A.; Van Hooft, J.I.M.; Van Bekkum, D.W.","year":"1968","unstructured":"Dicke KA, Van Hooft JIM, Van Bekkum DW. The selective elimination of immunologically competent cells from bone marrow and lymphatic cell mixtures. Transplantation 1968;6:562-70.","journal-title":"Transplantation"},{"key":"ref_24","first-page":"277","article-title":"Albumin density gradient purification of canine hemopoietic blood stem cells (HBSC): Long-term allogeneic engraftment without GVHreaction","volume":"7","author":"Korbling, M.; Fliedner, T.M.; Calvo, W.","year":"1979","unstructured":"Korbling M, Fliedner TM, Calvo W, et al. Albumin density gradient purification of canine hemopoietic blood stem cells (HBSC): Long-term allogeneic engraftment without GVHreaction. Exp Hematol 1979;7:277-88.","journal-title":"Exp Hematol"},{"key":"ref_25","first-page":"173","article-title":"Long survival and immunologic reconstitution following transplantation with syngeneic or allogeneic fetal liver and neonatal spleen cells","volume-title":"ofbone marrow transplantation","volume":"1","author":"Yunis, E.J.; Fernandes, G.; Smith, J.; Good, R.A.","year":"1976","unstructured":"Yunis EJ, Fernandes G, Smith J, Good RA. Long survival and immunologic reconstitution following transplantation with syngeneic or allogeneic fetal liver and neonatal spleen cells. In: Dupont B, Good RA, eds. Immunology ofbone marrow transplantation. New York: Grune & Stratton, 1976;1:173-7."},{"key":"ref_26","first-page":"153","article-title":"Restitution potentials of allogeneically or xenogeneically grafted lymphocyte-free hemopoietic stem cells","volume-title":"Immunology of bone marrow transplantation","author":"Muller-Ruchholtz, Wottage H.-U.; HK, Muller-Hermelink","year":"1979","unstructured":"Muller-Ruchholtz, Wottage H-U, Muller-Hermelink HK. Restitution potentials of allogeneically or xenogeneically grafted lymphocyte-free hemopoietic stem cells. In: Thierfelder S, Rodt H, Kolb HJ, eds. Immunology of bone marrow transplantation. Berlin, Heidelberg, New York: SpringerVerlag, 1979:153-77."},{"key":"ref_27","first-page":"257","article-title":"Effect of anti-T-cell globulin on GvHD leukemic patients treated with bone marrow transplantation","volume-title":"Transplant Proc 1981; 13","author":"Rodt, H.; Kolb, H.J.; Netzel, B.","unstructured":"Rodt H, Kolb HJ, Netzel B, et al. Effect of anti-T-cell globulin on GvHD leukemic patients treated with bone marrow transplantation. Transplant Proc 1981;13:257-61."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0140-6736(82)92619-8","article-title":"Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia","volume":"i:","author":"Prentice, H.G.; Blacklock, H.A.; Janossy, G.","year":"1982","unstructured":"Prentice HG, Blacklock HA, Janossy G, et al. Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia. Lancet 1982;i:700-4.","journal-title":"Lancet"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0140-6736(81)90647-4","article-title":"Transplantation for acute leukaemia with HLA-A and B non-identical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells","volume":"ii:","author":"Reisner, Y.; Kapoor, N.; Kirkpatrick, D.","year":"1981","unstructured":"Reisner Y, Kapoor N, Kirkpatrick D, et al. Transplantation for acute leukaemia with HLA-A and B non-identical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet 1981;ii:327-31.","journal-title":"Lancet"},{"key":"ref_30","first-page":"175","article-title":"High dose methyl prednisolone therapy in established acute graft-versus-host disease","volume":"41","author":"Prentice, H.G.; Bateman, S.M.; Bradstock, K.F.; I, Hoffbrand A.V.","year":"1980","unstructured":"Prentice HG, Bateman SM, Bradstock KF, Hoffbrand AV. I. High dose methyl prednisolone therapy in established acute graft-versus-host disease. In: Speck B, ed. Blut. Berlin, Heidelberg, New York: Springer Verlag, 1980;41:175-7."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/jcp.36.6.683","article-title":"Problems of infection after bone marrow transplantation","volume":"36","author":"JG, S.Watson","year":"1983","unstructured":"S Watson JG. Problems of infection after bone marrow transplantation. J Clin Pathol 1983;36:683-92.","journal-title":"J Clin Pathol"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM197712292972602","article-title":"Successful chemoprophylaxis for Pneumocystis carinii pneumonitis","volume":"297","author":"Hughes, W.T.; Kuhn, S.; Chaudhary, S.","year":"1977","unstructured":"Hughes WT, Kuhn S, Chaudhary S, et al. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1977;297:1419-26.","journal-title":"N Engl J Med"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1056\/NEJM198107093050202","article-title":"Acyclovir prophylaxis of herpes-simplex-virus infections. A randomised, double-blind, controlled trial in bone-marrow transplant recipients","volume":"305","author":"Saral, R.; Burns, W.H.; Laskin, O.L.; Santos, G.W.; Lietman, P.S.","year":"1981","unstructured":"Saral R, Burns WH, Laskin OL, Santos GW, Lietman PS. Acyclovir prophylaxis of herpes-simplex-virus infections. A randomised, double-blind, controlled trial in bone-marrow transplant recipients. N Engl J Med 1981;305:63-7.","journal-title":"N Engl J Med"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/bmj.287.6389.384","article-title":"Acyclovir prophylaxis of herpes virus infections in severely immunocompromised patients: a randomised double-blind trial","volume":"287","author":"Hann, I.M.; Prentice, H.G.; Blacklock, H.A.","year":"1983","unstructured":"Hann IM, Prentice HG, Blacklock HA, et al. Acyclovir prophylaxis of herpes virus infections in severely immunocompromised patients: a randomised double-blind trial. Br Med J 1983;287:384-8.","journal-title":"Br Med J"},{"key":"ref_35","first-page":"374","volume":"30","author":"Meyers, J.D.; Leszczynski, J.; Zia, J.A.; Levin, M.J.; Wright, G.G.; Thomas, E.D.","year":"1982","unstructured":"Meyers JD, Leszczynski J, Zia JA, Levin MJ, Wright GG, Thomas ED. Clin Res 1982;30:374A (Abstract).","journal-title":"Clin Res"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"671","DOI":"10.7326\/0003-4819-93-5-671","article-title":"Cytomegalovirus infections associated with leukocyte transfusions","volume":"93","author":"Winston, D.J.; Ho, W.G.; Howell, C.L.","year":"1980","unstructured":"Winston DJ, Ho WG, Howell CL, et al. Cytomegalovirus infections associated with leukocyte transfusions. Ann Intern Med 1980;93:671-5.","journal-title":"Ann Intern Med"},{"key":"ref_37","first-page":"826","article-title":"Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients","volume":"i:","author":"Hann, I.M.; Prentic, H.G.; Corringham, R.","year":"1982","unstructured":"' Hann IM, Prentic HG, Corringham R, et al. Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients. Lancet 1982;i:826-9.","journal-title":"Lancet"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jac\/10.6.489","article-title":"The pharmacokinetics of ketoconazole in severely immunocompromised patients","volume":"10","author":"Hann, I.M.; Prentice, H.G.; Keaney, M.","year":"1982","unstructured":"Hann IM, Prentice HG, Keaney M, et al. The pharmacokinetics of ketoconazole in severely immunocompromised patients. J Antimicrob Chemother 1982;10:489-96. Prentice","journal-title":"J Antimicrob Chemother"},{"key":"ref_39","first-page":"871","article-title":"A modified right atrial catheter for access to the venous system in marrow transplant recipients","volume":"148","author":"Hickman, R.O.; Buckner, C.D.; Clift, R.A.; Sanders, J.E.; Stewart, P.; Thomas, E.D.","year":"1979","unstructured":"Hickman RO, Buckner CD, Clift RA, Sanders JE, Stewart P, Thomas ED. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 1979;148:871-5.","journal-title":"Surg Gynecol Obstet"},{"issue":"9123","key":"ref_40","first-page":"51","article-title":"Immune deficiency after human marrow transplantation","volume":"7","author":"R, S.Witherspoon; L, Lum; R, Storb; ED, Thomas","year":"1983","unstructured":"S Witherspoon R, Lum L, Storb R, Thomas ED. Immune deficiency after human marrow transplantation. J Cell Biochem 1983;suppl 7A:Abs 9123:51.","journal-title":"J Cell Biochem"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0145-2126(82)90101-1","article-title":"Allogenic marrow transplantation for acute leukemia in relapse","volume":"6","author":"Badger, C.; Buckner, C.D.; Thomas, E.D.","year":"1982","unstructured":"Badger C, Buckner CD, Thomas ED, et al. Allogenic marrow transplantation for acute leukemia in relapse. Leuk Res 1982;6:383-7.","journal-title":"Leuk Res"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0145-2126(82)90104-7","article-title":"Allogeneic marrow transplantation using fractionated total body irradiation in patients with acute lymphoblastic leukemia in relapse","volume":"6","author":"Clift, R.A.; Buckner, C.D.; Thomas, E.D.","year":"1982","unstructured":"Clift RA, Buckner CD, Thomas ED, et al. Allogeneic marrow transplantation using fractionated total body irradiation in patients with acute lymphoblastic leukemia in relapse. Leuk Res 1982;6:401-7.","journal-title":"Leuk Res"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0145-2126(82)90102-3","article-title":"Allogeneic marrow transplantation for acute non-lymphoblastic leukemia in relapse using fractionated total body irradiation","volume":"6","author":"Buckner, C.D.; Clift, R.A.; Thomas, E.D.","year":"1982","unstructured":"Buckner CD, Clift RA, Thomas ED, et al. Allogeneic marrow transplantation for acute non-lymphoblastic leukemia in relapse using fractionated total body irradiation. Leuk Res 1982;6:389-94.","journal-title":"Leuk Res"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0145-2126(82)90103-5","article-title":"Allogeneic marrow transplantation for patients with acute non-lymphoblastic leukemia in second remission","volume":"6","author":"Buckner, C.D.; Clift, R.A.; Thomas, E.D.","year":"1982","unstructured":"Buckner CD, Clift RA, Thomas ED, et al..Allogeneic marrow transplantation for patients with acute non-lymphoblastic leukemia in second remission. Leuk Res 1982;6:395-9.","journal-title":"Leuk Res"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0145-2126(82)90105-9","article-title":"Allogeneic marrow transplantation for acute lymphoblastic leukemia in remission using fractionated total body irradiation","volume":"6","author":"s Clift RA; CD, Buckner; ED, Thomas","year":"1982","unstructured":"s Clift RA, Buckner CD, Thomas ED, et al. Allogeneic marrow transplantation for acute lymphoblastic leukemia in remission using fractionated total body irradiation. Leuk Res 1982;6:409-12.","journal-title":"Leuk Res"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2141.1982.tb03879.x","article-title":"Bone marrow transplantation for acute lymphoblastic leukaemia","volume":"52","author":"Barrett, A.J.; Kendra, JR, Lucas; C.F.","year":"1982","unstructured":"Barrett AJ, Kendra JR, Lucas CF, et al. Bone marrow transplantation for acute lymphoblastic leukaemia. Br J Haematol 1982;52:181-8.","journal-title":"Br J Haematol"},{"key":"ref_47","first-page":"1463","article-title":"Marrow transplantation for patients with acute non-lymphoblastic leukemia who achieve a first remission","volume":"66","author":"Thomas, E.D.; Clift, R.A.; Buckner, C.D.","year":"1982","unstructured":"Thomas ED, Clift RA, Buckner CD. Marrow transplantation for patients with acute non-lymphoblastic leukemia who achieve a first remission. Cancer Treat Rep 1982;66:1463-6.","journal-title":"Cancer Treat Rep"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0145-2126(82)90100-X","article-title":"Bone marrow transplantation","volume":"6","author":"CD, S.Bucker; RA, Clift; ED, Thomas","year":"1982","unstructured":"S Bucker CD, Clift RA, Thomas ED. Bone marrow transplantation. Leuk Res 1982;6:381-2.","journal-title":"Leuk Res"},{"issue":"109","key":"ref_49","first-page":"44","article-title":"Acute myelogenous leukemia","volume":"7","author":"Thomas, E.D.","year":"1983","unstructured":"-4Thomas ED. Acute myelogenous leukemia. J Cell Biochem 1983;Suppl 7A:Abs 0109:44.","journal-title":"J Cell Biochem"},{"key":"ref_50","first-page":"1047","article-title":"The place of bone marrow transplantation in acute myelogenous leukaemia","volume":"i:","author":"Powles, R.L.; Morgenstern, G.; Clink, H.M.","year":"1980","unstructured":"Powles RL, Morgenstern G, Clink HM, et al. The place of bone marrow transplantation in acute myelogenous leukaemia. Lancet 1980;i: 1047-50.","journal-title":"Lancet"},{"key":"ref_51","first-page":"248","article-title":"Antileukemic effect of graft versus host disease contributes to improved survival after allogeneic marrow transplantation","volume-title":"Transplant Proc 1981; 13","author":"PL, S.Weiden; N, Floumoy; JE, Sanders; KM, Sullivan; ED, Thomas","unstructured":"S Weiden PL, Floumoy N, Sanders JE, Sullivan KM, Thomas ED. Antileukemic effect of graft versus host disease contributes to improved survival after allogeneic marrow transplantation. Transplant Proc 1981;13:248-51."},{"issue":"112","key":"ref_52","first-page":"45","article-title":"Bone marrow transplantation for chronic myelogenous leukemia (CML)","volume":"7","author":"R, S7 Champlin; R, Mitsuyasu; RP, Gale","year":"1983","unstructured":"S7 Champlin R, Mitsuyasu R, Gale RP. Bone marrow transplantation for chronic myelogenous leukemia (CML). J Cell Biochem 1983;Suppl 7A:Abs 0112:45.","journal-title":"J Cell Biochem"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp.36.11.1207","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T09:34:37Z","timestamp":1765704877000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp.36.11.1207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,11]]},"references-count":52,"journal-issue":{"issue":"11","published-online":{"date-parts":[[1983,11,1]]},"published-print":{"date-parts":[[1983,11]]}},"alternative-id":["10.1136\/jcp.36.11.1207"],"URL":"https:\/\/doi.org\/10.1136\/jcp.36.11.1207","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,11]]}}}